EveryBaby detects preterm birth risk 21% more accurately

The device measures cervical length from week 14 and outperforms transvaginal ultrasound.

A prenatal device from startup EveryBaby is offering a major breakthrough in the early detection of premature birth risk—one of the most persistent and under-addressed challenges in maternal health.

Dabriel Choi, CEO and founder of the company, explained that current diagnostic tools were not designed to accurately predict preterm birth, especially for asymptomatic, low-risk mothers.

“The challenge with preterm birth is there is not really a product that can detect premature birth, and most devices were not really invented to predict preterm birth,” he told Healthcare Asia during the Asia Summit on Global Health in Hong Kong.

The EveryBaby device works by measuring cervical length—an important early indicator of premature labor risk.

Choi highlighted a key performance advantage of their device: “We have compared our device with transvaginal ultrasounds and… we have shown that our device is 21% more accurate than any other device that is currently in the market.”

That difference is particularly crucial for expectant mothers without visible symptoms. “Our solution works for mothers with asymptomatic, low-risk profiles, which means mothers who do not show signs of early labor,” Choi said.